Pharmaceutical firms concerned over results of drug price re-assessment

Domestic pharmaceutical industry expressed concern about possible fallout from the government's re-assessment work on drug prices, as it places more emphasis on the cutback of drug prices.

Following the recent completion of drug price re-assessment work by the Health Insurance Review Agency over 306 items from 98 ingredients listed in the reimbursable drugs from September 1st, 1999 to August...